Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

POZN

Pozen, Inc. (MM) (POZN)

Pozen, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:POZN

Date	Heure	Source	Titre	Symbole	Société
14/03/2016	20h08	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:POZN	Pozen, Inc. (MM)
14/03/2016	18h23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:POZN	Pozen, Inc. (MM)
14/03/2016	18h21	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:POZN	Pozen, Inc. (MM)
19/10/2009	15h01	PR Newswire (US)	Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers	NASDAQ:POZN
16/10/2009	14h45	Dow Jones News	AstraZeneca Submits EU Marketing Application For Vimovo	NASDAQ:POZN	Pozen Inc.
31/08/2009	14h39	Dow Jones News	Pozen Earns $10 Million From AstraZeneca As FDA Accepts Drug Application	NASDAQ:POZN	Pozen Inc.
30/06/2009	14h57	Dow Jones News	AstraZeneca Partner Pozen Submits PN400 New Drug Application	NASDAQ:POZN	Pozen Inc.
08/06/2007	19h00	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks	NASDAQ:POZN
02/05/2007	21h12	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks	NASDAQ:POZN
02/05/2007	21h09	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms	NASDAQ:POZN
03/05/2006	23h21	PR Newswire (US)	American Stock Exchange to Trade Options on Six Securities	NASDAQ:POZN